BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26404510)

  • 1. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
    Takayama K; Misawa A; Suzuki T; Takagi K; Hayashizaki Y; Fujimura T; Homma Y; Takahashi S; Urano T; Inoue S
    Nat Commun; 2015 Sep; 6():8219. PubMed ID: 26404510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
    Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.
    Mahfoudhi E; Talhaoui I; Cabagnols X; Della Valle V; Secardin L; Rameau P; Bernard OA; Ishchenko AA; Abbes S; Vainchenker W; Saparbaev M; Plo I
    DNA Repair (Amst); 2016 Jul; 43():78-88. PubMed ID: 27289557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
    Minor EA; Court BL; Young JI; Wang G
    J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
    Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
    Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
    Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
    Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
    Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
    PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET2 binds the androgen receptor and loss is associated with prostate cancer.
    Nickerson ML; Das S; Im KM; Turan S; Berndt SI; Li H; Lou H; Brodie SA; Billaud JN; Zhang T; Bouk AJ; Butcher D; Wang Z; Sun L; Misner K; Tan W; Esnakula A; Esposito D; Huang WY; Hoover RN; Tucker MA; Keller JR; Boland J; Brown K; Anderson SK; Moore LE; Isaacs WB; Chanock SJ; Yeager M; Dean M; Andresson T
    Oncogene; 2017 Apr; 36(15):2172-2183. PubMed ID: 27819678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.
    Pirola CJ; Scian R; Gianotti TF; Dopazo H; Rohr C; Martino JS; Castaño GO; Sookoian S
    Medicine (Baltimore); 2015 Sep; 94(36):e1480. PubMed ID: 26356709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
    Bohrer LR; Chen S; Hallstrom TC; Huang H
    Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
    Zhang LY; Li PL; Wang TZ; Zhang XC
    Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
    Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
    EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
    Shen Q; Zhang Q; Shi Y; Shi Q; Jiang Y; Gu Y; Li Z; Li X; Zhao K; Wang C; Li N; Cao X
    Nature; 2018 Feb; 554(7690):123-127. PubMed ID: 29364877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.
    Jia J; Shi Y; Chen L; Lai W; Yan B; Jiang Y; Xiao D; Xi S; Cao Y; Liu S; Cheng Y; Tao Y
    Theranostics; 2017; 7(16):3920-3932. PubMed ID: 29109788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, α-Ketoglutarate (α-KG), and DNA hydroxymethylation levels by interleukin-1β in primary human chondrocytes.
    Haseeb A; Makki MS; Haqqi TM
    J Biol Chem; 2014 Mar; 289(10):6877-6885. PubMed ID: 24469454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
    Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
    Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
    Mariani CJ; Vasanthakumar A; Madzo J; Yesilkanal A; Bhagat T; Yu Y; Bhattacharyya S; Wenger RH; Cohn SL; Nanduri J; Verma A; Prabhakar NR; Godley LA
    Cell Rep; 2014 Jun; 7(5):1343-1352. PubMed ID: 24835990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.